Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats

Diabetes

Volumn 60, Issue 11, 2011, Pages 2730-2739

  De Lange, Pieter ^a   Cioffi, Federica ^b   Senese, Rosalba ^a   Moreno, Maria ^b   Lombardi, Assunta ^c   Silvestri, Elena ^b   De Matteis, Rita ^d   Lionetti, Lillà ^c   Mollica, Maria Pina ^c   Goglia, Fernando ^b   Lanni, Antonia ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF URBINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CHOLESTEROL; DIIODOTHYRONINE; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; THYROID HORMONE RECEPTOR BETA; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FUNCTIONAL PROTEOMICS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOMICS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; IMMUNOBLOTTING; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTRACELLULAR SIGNALING; LEAN BODY WEIGHT; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER MITOCHONDRION; MALE; METABOLIC PARAMETERS; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; TRANSIENT TRANSFECTION; UPREGULATION;

ANIMALS; CELL LINE; CELL NUCLEUS; DIETARY FATS; DIIODOTHYRONINES; ENZYME ACTIVATORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; HOMEOSTASIS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIPIDS; LIVER; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; SIRTUIN 1; THYROID HORMONE RECEPTORS BETA; WEIGHT GAIN;

EID: 80755184749     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0207     Document Type: Article

References (34)

1. Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation 2003;108:1546-1551 (Pubitemid 37187778)
2. Barness LA, Opitz JM, Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A 2007;143A:3016-3034 (Pubitemid 350274816)
3. Oppenheimer JH, Schwartz HL, Lane JT, Thompson MP. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. J Clin Invest 1991;87:125-132
4. Moreno M, de Lange P, Lombardi A, Silvestri E, Lanni A, Goglia F. Metabolic effects of thyroid hormone derivatives. Thyroid 2008;18:239-253 (Pubitemid 351271526)
5. Baxter JD, Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 2009;8:308-320
6. Cioffi F, Lanni A, Goglia F. Thyroid hormones, mitochondrial bioenergetics and lipid handling. Curr Opin Endocrinol Diabetes Obes 2010;17:402-407
7. Ribeiro MO. Effects of thyroid hormone analogs on lipid metabolism and thermogenesis. Thyroid 2008;18:197-203 (Pubitemid 351271536)
8. Lanni A, Moreno M, Lombardi A, et al. 3,5-Diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J 2005;19:1552-1554 (Pubitemid 41279028)
9. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007;8:774-785 (Pubitemid 47462132)
10. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-342 (Pubitemid 44764104)
11. Gerhart-Hines Z, Rodgers JT, Bare O, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007;26:1913-1923 (Pubitemid 46624046)
12. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127:1109-1122 (Pubitemid 44894520)
13. Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004;429:771-776 (Pubitemid 38833129)
14. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-118 (Pubitemid 40349395)
15. Rodgers JT, Puigserver P. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci U S A 2007;104:12861-12866 (Pubitemid 47255245)
16. Feige JN, Lagouge M, Cantò C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 2008;8:347-358
17. Lionetti L, Mollica MP, Crescenzo R, et al. Skeletal muscle subsarcolemmal mitochondrial dysfunction in high-fat fed rats exhibiting impaired glucose homeostasis. Int J Obes (Lond) 2007;31:1596-1604 (Pubitemid 47482654)
18. Mollica MP, Lionetti L, Moreno M, et al. 3,5-Diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. J Hepatol 2009;51:363-370
19. Moreno M, Lanni A, Lombardi A, Goglia F. How the thyroid controls metabolism in the rat: different roles for triiodothyronine and diiodothyronines. J Physiol 1997;505:529-538 (Pubitemid 28043394)
20. Alexson SEH, Nedergaard J. A novel type of short- and medium-chain acyl-CoA hydrolases in brown adipose tissue mitochondria. J Biol Chem 1988;263:13564-13571
21. de Lange P, Farina P, Moreno M, et al. Sequential changes in the signal transduction responses of skeletal muscle following food deprivation. FASEB J 2006;20:2579-2581
22. de Lange P, Feola A, Ragni M, et al. Differential 3,5,3′- triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of Fatty acids. Endocrinology 2007;148:4064-4072 (Pubitemid 47105882)
23. Senese R, Valli V, Moreno M, et al. Uncoupling protein 3 expression levels influence insulin sensitivity, fatty acid oxidation, and related signaling pathways. Pflugers Arch 2011;461:153-164
24. Silvestri E, Moreno M, Schiavo L, et al. A proteomics approach to identify protein expression changes in rat liver following administration of 3,5,3′-triiodo-L-thyronine. J Proteome Res 2006;5:2317-2327 (Pubitemid 44330825)
25. Lombardi A, Silvestri E, Cioffi F, et al. Defining the transcriptomic and proteomic profiles of rat ageing skeletal muscle by the use of a cDNA array, 2D- and Blue native-PAGE approach. J Proteomics 2009;72:708-721
26. Solanes G, Pedraza N, Iglesias R, Giralt M, Villarroya F. The human uncoupling protein-3 gene promoter requires MyoD and is induced by retinoic acid in muscle cells. FASEB J 2000;14:2141-2143
27. Cable EE, Finn PD, Stebbins JW, et al. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 2009;49:407-417
28. Fulco M, Sartorelli V. Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle 2008;7:3669-3679
29. Cantó C, Jiang LQ, Deshmukh AS, et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 2010;11:213-219
30. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009;9:327-338
31. Ponugoti B, Kim D-H, Xiao Z, et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 2010;285:33959-33970
32. Banks AS, Kon N, Knight C, et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 2008;8:333-341
33. Lynch CJ, Fox H, Hazen SA, Stanley BA, Dodgson S, Lanoue KF. Role of hepatic carbonic anhydrase in de novo lipogenesis. Biochem J 1995;310:197-202
34. Supuran CT, Di Fiore A, De Simone G. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs 2008;13:383-392 (Pubitemid 351957352)